Fmoc-γ-carboxy γ-(di-tert-butyl ester)-L-glutamic acid
Need Assistance?
  • US & Canada:
    +
  • UK: +

Fmoc-γ-carboxy γ-(di-tert-butyl ester)-L-glutamic acid

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
Fmoc-Amino Acids
Catalog number
BAT-005549
CAS number
111662-64-7
Molecular Formula
C29H35NO8
Molecular Weight
525.6
Fmoc-γ-carboxy γ-(di-tert-butyl ester)-L-glutamic acid
IUPAC Name
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-4-[(2-methylpropan-2-yl)oxycarbonyl]-5-oxopentanoic acid
Synonyms
Fmoc-γ-carboxy-γ-(di-tert-butyl ester)-L-glutamic acid; Fmoc-γ-carboxy-L-Glu(OtBu)2-OH
Appearance
White crystalline powder
Purity
≥ 99% (HPLC)
Melting Point
123-129 °C (crystals from ethyl acetate/hexanes)
Storage
Store at-20°C
InChI
InChI=1S/C29H35NO8/c1-28(2,3)37-25(33)21(26(34)38-29(4,5)6)15-23(24(31)32)30-27(35)36-16-22-19-13-9-7-11-17(19)18-12-8-10-14-20(18)22/h7-14,21-23H,15-16H2,1-6H3,(H,30,35)(H,31,32)/t23-/m0/s1
InChI Key
XJRUHYXXHXECDI-QHCPKHFHSA-N
Canonical SMILES
CC(C)(C)OC(=O)C(CC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C(=O)OC(C)(C)C

Fmoc-γ-carboxy γ-(di-tert-butyl ester)-L-glutamic acid is a protected form of the amino acid glutamic acid, primarily used in peptide synthesis. Here are some key applications of Fmoc-γ-carboxy γ-(di-tert-butyl ester)-L-glutamic acid:

Peptide Synthesis: This compound is commonly used in solid-phase peptide synthesis as a building block for assembling peptides. The Fmoc group provides a stable protection for the amino functional group, preventing unwanted side reactions during synthesis. The di-tert-butyl ester protects the carboxyl group, making it selectively removable under mild acidic conditions.

Protein Engineering: Researchers utilize this compound to introduce glutamic acid residues into engineered proteins or peptides, aiding in the study of protein functions and interactions. It offers precise control over the introduction of functional groups, assisting in the examination of protein folding, stability, and activity. By incorporating modified amino acids like this, scientists can create proteins with enhanced or novel properties.

Medicinal Chemistry: In drug development, Fmoc-γ-carboxy γ-(di-tert-butyl ester)-L-glutamic acid is utilized as a precursor for synthesizing peptide-based drugs and therapeutic agents. Its protection groups allow for the assembly of complex peptide structures that can act as enzyme inhibitors or receptor ligands. This versatility is essential in the creation of targeted therapies with specific biological activities.

Nanotechnology: In the field of nanotechnology, this compound is employed in the fabrication of peptide-based nanostructures and materials. The precisely controlled chemistry of peptide bonds allows for the creation of self-assembling nanostructures with potential applications in drug delivery and tissue engineering. These peptide-based materials can be designed to have unique mechanical and chemical properties suitable for various biotechnological applications.

1. Structure of a Gla-containing dipeptide. The crystal structure of (+/-)-N-carbobenzoxy-(gamma,gamma'-DI-tertbutyl)-gamma-carboxyglutamylglycine ethyl ester
E J Valente, R G Hiskey, D J Hodgson Biochim Biophys Acta. 1979 Aug 28;579(2):466-8. doi: 10.1016/0005-2795(79)90074-6.
The crystal and molecular structure of a dipeptide containing a blocked gamma-carboxyglutamyl (Gla) residue is presented. Two intermolecular hydrogen bonds link the amides with carbonyl groups in the dipeptide backbone, but the protected gamma-carboxy groups on the modified glutamic acid are not hydrogen bonded.
2. Synthesis of potent antagonists of substance P by modifying the methionyl and glutaminyl residues of its C-terminal hexapeptide and without using D-amino acids
A Manolopoulou, K Karagiannis, G Stavropoulos, C Poulos, C C Jordan, R M Hagan Int J Pept Protein Res. 1993 Apr;41(4):411-4. doi: 10.1111/j.1399-3011.1993.tb00458.x.
Analogues of [Orn6]-SP6-11 have been synthesized in which the Met11-NH2 residue is replaced by the alpha, gamma-dimethyl, alpha, gamma-dibenzyl and alpha, gamma-di-tert-butyl esters of glutamic acid. These analogues were tested in three in vitro preparations representative of NK-1, NK-2 and NK-3 receptor types for agonist and antagonist activity. The dimethyl analogue is a selective full agonist in the NK-1 receptor type and a weak antagonist in the other two receptor types, while the dibenzyl and the di-tert-butyl analogues are potent antagonists in the NK-1 receptor type and weak antagonists in the other two receptor types. It is concluded that appropriate modification at the alpha-carboxamide and the side chain of the methionine residue of substance P may induce antagonism without using D-amino acids.
Online Inquiry
Inquiry Basket